2 employees
Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .
2017
$1.3M
from 4 investors over 4 rounds
Cytochroma_uk raised $1.3M on December 16, 2021
Investors: Investing Women Angels and Angel Academe
Cytochroma_uk raised undisclosed on December 16, 2021
Investors: Scottish Enterprise and Innovate UK